The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue

More than 80% of multiple sclerosis (MS) patients suffer from fatigue. Despite this, there are few therapeutic options and evidence-based pharmacological treatments are lacking. The associated societal burden is substantial (MS fatigue is a major reason for part-time employment or early retirement),...

Descripción completa

Detalles Bibliográficos
Autores principales: Veauthier, Christian, Hasselmann, Helge, Gold, Stefan M., Paul, Friedemann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121967/
https://www.ncbi.nlm.nih.gov/pubmed/27904656
http://dx.doi.org/10.1186/s13167-016-0073-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121967/
https://www.ncbi.nlm.nih.gov/pubmed/27904656
http://dx.doi.org/10.1186/s13167-016-0073-3

Ejemplares similares